Table 1.
Open in new tab

Patient Grouping According to Clinical Characteristics and Location of the Cysts With the Stage Likely Most Influencing Their Serological Status

GroupPatients, No.Patients, No. (%)
TotalNo Albendazole TreatmentAlbendazole <5 y EarlieraAlbendazole >5 y EarlierbHepatic CystsExtrahepatic Cysts
CE172507 (100.0)0
CE292709 (100)0
CE3a27720026 (96.3)1 (3.7)
CE3b511437044 (86.3)7 (13.7)
CE436823534 (94.4)2 (5.6)
CE518122416 (88.9)2 (11.1)
Postsurgical25025021 (84.0)4 (16.0)
Total173451199157 (90.8)16 (9.2)
GroupPatients, No.Patients, No. (%)
TotalNo Albendazole TreatmentAlbendazole <5 y EarlieraAlbendazole >5 y EarlierbHepatic CystsExtrahepatic Cysts
CE172507 (100.0)0
CE292709 (100)0
CE3a27720026 (96.3)1 (3.7)
CE3b511437044 (86.3)7 (13.7)
CE436823534 (94.4)2 (5.6)
CE518122416 (88.9)2 (11.1)
Postsurgical25025021 (84.0)4 (16.0)
Total173451199157 (90.8)16 (9.2)
a

Albendazole intake ended <5 years before collection of serum samples for this study.

b

Albendazole intake ended >5 years before collection of serum samples for this study.

Table 1.
Open in new tab

Patient Grouping According to Clinical Characteristics and Location of the Cysts With the Stage Likely Most Influencing Their Serological Status

GroupPatients, No.Patients, No. (%)
TotalNo Albendazole TreatmentAlbendazole <5 y EarlieraAlbendazole >5 y EarlierbHepatic CystsExtrahepatic Cysts
CE172507 (100.0)0
CE292709 (100)0
CE3a27720026 (96.3)1 (3.7)
CE3b511437044 (86.3)7 (13.7)
CE436823534 (94.4)2 (5.6)
CE518122416 (88.9)2 (11.1)
Postsurgical25025021 (84.0)4 (16.0)
Total173451199157 (90.8)16 (9.2)
GroupPatients, No.Patients, No. (%)
TotalNo Albendazole TreatmentAlbendazole <5 y EarlieraAlbendazole >5 y EarlierbHepatic CystsExtrahepatic Cysts
CE172507 (100.0)0
CE292709 (100)0
CE3a27720026 (96.3)1 (3.7)
CE3b511437044 (86.3)7 (13.7)
CE436823534 (94.4)2 (5.6)
CE518122416 (88.9)2 (11.1)
Postsurgical25025021 (84.0)4 (16.0)
Total173451199157 (90.8)16 (9.2)
a

Albendazole intake ended <5 years before collection of serum samples for this study.

b

Albendazole intake ended >5 years before collection of serum samples for this study.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close